举元煎加味治疗气虚型月经过多疗效观察.docVIP

  • 69
  • 0
  • 约4.39千字
  • 约 8页
  • 2018-08-15 发布于福建
  • 举报

举元煎加味治疗气虚型月经过多疗效观察.doc

举元煎加味治疗气虚型月经过多疗效观察

举元煎加味治疗气虚型月经过多的疗效观察   摘 要:目的 观察举元煎治疗气虚型月经过多的临床效果。方法 选取2016年1月~12月在我院诊治的气虚型月经过多患者90例,随机分为治疗组和对照组,每组45例。对照组采用常规西药治疗,治疗组以中药举元煎为主再根据中医辩证分型进行加味治疗,对比两组患者的临床症状、红细胞化验结果以及临床疗效。结果 与对照组相比,治疗组在经期和经量、经色、经质及血常规红细胞化验检查等方面显著改善,差异具有统计学意义(P0.05);治疗组总有效率为95.56%,高于对照组的84.44%,差异有统计学意义(P0.05)。结论 举元煎加味治疗气虚型月经过多临床效果显著,标本兼治,值得临床推广应用。   关键词:举元煎;月经过多;气虚   中图分类号:R271.111 文献标识码:A DOI:10.3969/j.issn.1006-1959.2018.04.053   文章编号:1006-1959(2018)04-0145-02   Abstract:Objective To observe the clinical effect of Ju yuan-jian decoction in treating menstrual hypermenorrhea of qi deficiency type.Methods 90 patients with Qi deficiency type menorrhagia in our hospital from January to December in 2016 were randomly divided into the treatment group and the control group,with 45 cases in each group.The control group was treated with conventional western medicine.The treatment group was mainly treated with traditional Chinese medicineJu Yuan Jian decoction.The clinical symptoms,red blood cell test results and clinical efficacy of the two groups were compared.Results Compared with the control group, the treatment group improved significantly in menstrual period and volume,color,quality and routine erythrocyte examination.The difference was statistically significant(P0.05).The total effective rate of the treatment group was 95.56%,which was higher than that of the control group 84.44%,the difference was statistically significant(P0.05).Conclusion The treatment of Qi deficiency type menorrhagia with the addition and subtraction of Ju Yuan Jian decoction has remarkable clinical effect and is worth popularizing and applying.   Key words:Ju Yuan Jian decoction;Menorrhagia;Qi deficiency   月?过多(heavy menstrual bleeding,HMB)是指月经量较正常明显增多或超过80 ml,连续超过2个月经周期以上,而周期基本正常者[1]。气虚型月经过多在临床中较为常见,表现为经来量多,色淡质稀,兼见面色?s白,气短懒言神疲乏力,小腹空坠,舌淡,脉细,若不及时准确治疗,可发展为崩漏,严重影响患者的健康生活。笔者观察了举元煎治疗气虚型月经过多的临床效果,现报道如下。   1资料与方法   1.1一般资料 选取2016年1月~12月在我院诊治的气虚型月经过多患者90例,所有程序通过医院伦理委员会批准。将患者随机分为治疗组和对照组,每组45例。对照组患者年龄20~43岁,平均年龄(34.2±0.34)岁;病程2.4~13个

文档评论(0)

1亿VIP精品文档

相关文档